Potential Expanded Indications for Neprilysin Inhibitors.

Riddell, Elizabeth; Vader, Justin M

Riddell, Elizabeth; Vader, Justin M.

Affiliation

Riddell E; Cardiovascular Division, Washington University School of Medicine, 660 S. Euclid Ave., Box 8086, St Louis, MO, 63110, USA.
Vader JM; Cardiovascular Division, Washington University School of Medicine, 660 S. Euclid Ave., Box 8086, St Louis, MO, 63110, USA. jvader@wustl.edu.

Curr Heart Fail Rep ; 14(2): 134-145, 2017 04.

Article in En | MEDLINE | ID: mdl-28281174

Subject(s)

Aminobutyrates/therapeutic use; Angiotensin Receptor Antagonists/therapeutic use; Heart Failure/drug therapy; Neprilysin/antagonists & inhibitors; Tetrazoles/therapeutic use; Animals; Biphenyl Compounds; Drug Combinations; Drug Therapy, Combination; Humans; Valsartan

Key words

Cardiovascular disease; Heart failure; Neprilysin inhibitors; Sacubitril/valsartan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Tetrazoles / Neprilysin / Angiotensin Receptor Antagonists / Aminobutyrates / Heart Failure Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Curr Heart Fail Rep Journal subject: CARDIOLOGIA Year: 2017 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google